Login or sign up
For business

Naurex

4.4ยท 11 reviews
Average ratingGreat
4.4/ 5

Based on 11 reviews

555%
427%
318%
20%
10%
Ask AI

Ask Trustburn about Naurex

Based on 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Andrew Weissman
Reviews 1

I recently had the opportunity to work with Naurex and I must say, they exceeded my expectations. The level of professionalism and expertise that their team brought to the table was truly outstanding. From the initial consultation to the final product delivery, every step of the process was handled with utmost care and attention. The attention to detail and the dedication shown by their team was truly commendable. I would highly recommend Naurex to anyone looking for top-notch services.

Lasalette Kershaw
Reviews 1

I recently worked with a company on a project and they did an amazing job! Their professionalism and expertise were exceptional. They delivered a high-quality product that exceeded my expectations. I highly recommend them for anyone looking for top-notch services.

Molly Small
Reviews 1

I'm really impressed with the services provided by Naurex. Their team is highly professional and delivers exceptional results. The attention to detail and commitment to customer satisfaction is outstanding. I would definitely recommend Naurex to anyone looking for reliable services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Naurex

Naurex Inc. is a clinical-stage company developing novel therapies for depression and other CNS disorders based on a new mechanism of action for modulating the N-methyl-D-aspartic acid receptor (NMDAR). Using these discoveries, Naurex researchers have generated novel chemical drug classes known as glycine-site functional partial agonists (GFPAs), which modulate the receptor in a different way than existing NMDAR agents. The company's drug development programs based on its GFPA NMDAR modulators include the first-generation molecule, GLYX-13, the second-generation NRX-1050 small molecule series and additional compounds from Naurex's platform of novel NMDAR modulators.

Website
naurex.com
Address
1801 Maple Ave Ste 70
Categories
Chemicals